Four tables listing the strengths, weaknesses, opportunities, and threats for the NEWMEDS initiative

FIGURE 6-1Strengths, weaknesses, opportunities, and threats for the NEWMEDS initiative

NOTE: EFPIA = Federation of European Pharmaceutical Industries and Associations.

SOURCE: Steckler presentation, March 29, 2012.

From: 6, Addressing the Translational Disconnect

Cover of Improving the Utility and Translation of Animal Models for Nervous System Disorders
Improving the Utility and Translation of Animal Models for Nervous System Disorders: Workshop Summary.
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders.
Washington (DC): National Academies Press (US); 2013.
Copyright © 2013, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.